Antiplatelet effects of aspirin vary with level of P2Y(12) receptor blockade supplied by either ticagrelor or prasugrel

Lignende værker

• IN THE PRESENCE OF STRONG P2Y(12) RECEPTOR BLOCKADE, ASPIRIN PROVIDES LITTLE ADDITIONAL INHIBITION OF PLATELET AGGREGATION
  af: Armstrong, Paul C.J., et al.
  Udgivet: (2011)
• Aspirin has little additional anti-platelet effect in healthy volunteers receiving prasugrel
  af: LEADBEATER, P D M, et al.
  Udgivet: (2011)
• Randomized Assessment of Ticagrelor Versus Prasugrel Antiplatelet Effects in Patients With Diabetes
  af: Alexopoulos, Dimitrios, et al.
  Udgivet: (2013)
• Previous Antiplatelet Therapy on Ticagrelor-Aspirin and Clopidogrel-Aspirin Efficacy in Intracranial Artery Stenosis
  af: Qin Xu, et al.
  Udgivet: (2025-09-01)
• Ticagrelor as an Alternative Antiplatelet Therapy in Cardiac Patients Non-Sensitive to Aspirin
  af: Khan, Hamzah, et al.
  Udgivet: (2020)